PACS, RIS, and CVIS | BRIC | 2015 | Market Analysis
MNCs’ PACS, RIS, and CVIS will increasingly penetrate the local competitor-dominated markets in the BRIC region because health care facilities in these rapidly expanding emerging markets seek the advanced clinical features and brand recognition that MNCs provide.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for PACS, RIS, and CVIS in Brazil, Russia, India, and China across a 10-year period.
